Gandhi V - Search Results

1

Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.

Tettamanti S, Rotiroti MC, Giordano Attianese GMP, Arcangeli S, Zhang R, Banerjee P, Galletti G, McManus S, Mazza M, Nicolini F, Martinelli G, Ivan C, Veliz Rodriguez T, Barbaglio F, Scarfò L, Ponzoni M, Wierda W, Gandhi V, Keating M, Biondi A, Caligaris-Cappio F, Biagi E, Ghia P, Bertilaccio MTS. Tettamanti S, et al. Among authors: gandhi v. Leuk Lymphoma. 2022 Jul;63(7):1566-1579. doi: 10.1080/10428194.2022.2043299. Epub 2022 Mar 8. Leuk Lymphoma. 2022. PMID: 35259043 Free PMC article.

2

Inhibition of fludarabine metabolism by arabinosylcytosine during therapy.

Kemena A, Gandhi V, Shewach DS, Keating M, Plunkett W. Kemena A, et al. Among authors: gandhi v. Cancer Chemother Pharmacol. 1992;31(3):193-9. doi: 10.1007/BF00685547. Cancer Chemother Pharmacol. 1992. PMID: 1464155 Free article.

3

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.

Gandhi V, Kemena A, Keating MJ, Plunkett W. Gandhi V, et al. Cancer Res. 1992 Feb 15;52(4):897-903. Cancer Res. 1992. PMID: 1737352

4

Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy.

Gandhi V, Nowak B, Keating MJ, Plunkett W. Gandhi V, et al. Blood. 1989 Nov 1;74(6):2070-5. Blood. 1989. PMID: 2478221 Free article.

5

Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.

Danhauser L, Plunkett W, Liliemark J, Gandhi V, Iacoboni S, Keating M. Danhauser L, et al. Among authors: gandhi v. Leukemia. 1987 Sep;1(9):638-43. Leukemia. 1987. PMID: 3478543

6

Fludarabine phosphate: a new active agent in hematologic malignancies.

Keating MJ, O'Brien S, Plunkett W, Robertson LE, Gandhi V, Estey E, Dimopoulos M, Cabanillas F, Kemena A, Kantarjian H. Keating MJ, et al. Among authors: gandhi v. Semin Hematol. 1994 Jan;31(1):28-39. Semin Hematol. 1994. PMID: 7510070 Review. No abstract available.

7

The expanding role of fludarabine in hematologic malignancies.

Keating MJ, O'Brien S, Robertson LE, Kantarjian H, Dimopoulos M, McLaughlin P, Cabanillas F, Gregoire V, Li YY, Gandhi V, et al. Keating MJ, et al. Among authors: gandhi v. Leuk Lymphoma. 1994;14 Suppl 2:11-6. doi: 10.3109/10428199409052690. Leuk Lymphoma. 1994. PMID: 7533576 Review.

8

Fludarabine inhibits DNA replication: a rationale for its use in the treatment of acute leukemias.

Gandhi V, Huang P, Plunkett W. Gandhi V, et al. Leuk Lymphoma. 1994;14 Suppl 2:3-9. doi: 10.3109/10428199409052689. Leuk Lymphoma. 1994. PMID: 7881348 Review.

9

Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemia.

Gandhi V, Du M, Kantarjian HM, Plunkett W. Gandhi V, et al. Leukemia. 1994 Sep;8(9):1463-8. Leukemia. 1994. PMID: 8090026

10

Fludarabine for treatment of adult acute myelogenous leukemia.

Gandhi V. Gandhi V. Leuk Lymphoma. 1993;11 Suppl 2:7-13. doi: 10.3109/10428199309064255. Leuk Lymphoma. 1993. PMID: 8124234 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page